About Symbiotec
Symbiotec is a company based in Indore (India) founded in 2002 was acquired by Rosewood Private Intvestments in December 2018.. Symbiotec has raised $61.01 million across 4 funding rounds from investors including Actis, Franklin Templeton and British International Investment. The company has 1,822 employees as of May 31, 2025. Symbiotec offers products and services including Cortico-Steroid API, Steroid-Hormone API, and Intermediates. Symbiotec operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Jubilant Pharma and SeQuent, among others.
- Headquarter Indore, India
- Employees 1822 as on 31 May, 2025
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Symbiotec Pharmalab
-
Annual Revenue
$87.38 M (USD)26as on Mar 31, 2024
-
Net Profit
$12.25 M (USD)313as on Mar 31, 2024
-
EBITDA
$21.55 M (USD)137as on Mar 31, 2024
-
Total Equity Funding
$61.01 M (USD)
in 4 rounds
-
Latest Funding Round
$48 M (USD), Series C
Oct 13, 2013
-
Investors
Actis
& 8 more
-
Employee Count
1822
as on May 31, 2025
-
Acquired by
Rosewood Private Intvestments
(Dec 18, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Symbiotec
Symbiotec offers a comprehensive portfolio of products and services, including Cortico-Steroid API, Steroid-Hormone API, and Intermediates. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Active ingredients for corticosteroids in therapies like pain management
APIs for steroid hormones used in dermatology and pediatrics
Raw materials for API synthesis in pharmaceutical applications
Unlock access to complete
Funding Insights of Symbiotec
Symbiotec has successfully raised a total of $61.01M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $48 million completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $48.0M
-
First Round
First Round
(06 Aug 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2013 | Amount | Series C - Symbiotec | Valuation | Actis | |
| Mar, 2013 | Amount | Angel Round - Symbiotec | Valuation | R S Shapeti |
|
| Sep, 2011 | Amount | Series A - Symbiotec | Valuation | Franklin Templeton Investments |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Symbiotec
Symbiotec has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Actis, Franklin Templeton and British International Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sustainable infrastructure projects are invested in for essential services.
|
Founded Year | Domain | Location | |
|
Government agency focused on small and medium-sized businesses
|
Founded Year | Domain | Location | |
|
Investments in multiple sectors are managed by Soyumm Marketing.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Symbiotec
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Symbiotec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Symbiotec Comparisons
Competitors of Symbiotec
Symbiotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Jubilant Pharma and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Symbiotec
Frequently Asked Questions about Symbiotec
When was Symbiotec founded?
Symbiotec was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Where is Symbiotec located?
Symbiotec is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Is Symbiotec a funded company?
Symbiotec is a funded company, having raised a total of $61.01M across 4 funding rounds to date. The company's 1st funding round was a Series A of $9.22M, raised on Aug 06, 2007.
How many employees does Symbiotec have?
As of May 31, 2025, the latest employee count at Symbiotec is 1,822.
What is the annual revenue of Symbiotec?
Annual revenue of Symbiotec is $87.38M as on Mar 31, 2024.
What does Symbiotec do?
Symbiotec was established in 2002 in Indore, India, as a manufacturer in the pharmaceutical sector. Non-sterile APIs and intermediates derived from steroid hormones are produced, targeting therapeutic areas such as gastrointestinal ailments, cardiovascular disease, pain management, pediatrics, anti-infectives, and dermatology. Regulatory-compliant solutions are offered, alongside operations in research and quality control laboratories.
Who are the top competitors of Symbiotec?
Symbiotec's top competitors include Laurus Labs, Sterling Pharma Solutions and Provepharm Life Solutions.
What products or services does Symbiotec offer?
Symbiotec offers Cortico-Steroid API, Steroid-Hormone API, and Intermediates.
Who are Symbiotec's investors?
Symbiotec has 9 investors. Key investors include Actis, Franklin Templeton, British International Investment, R S Shapeti, and Rakesh Jhunjhunwala.
What is Symbiotec's valuation?
The valuation of Symbiotec is $32.19M as of Mar 2013.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.